Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback